PATH (Peer Advanced Training in Harm Reduction) to Reducing Burnout Among Peers Who Deliver Harm Reduction Services (R61 Phase Pilot)

NCT07218562 · Status: ENROLLING_BY_INVITATION · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-17

No results posted yet for this study

Summary

The investigators propose to develop and test the effectiveness of PATH (Peer Advanced Training in Harm reduction) as an educational workforce intervention for improving peer recovery support specialists' (PRSS) harm reduction (HR) service delivery ability and quality and as a PRSS workforce and service system support. The PATH intervention combines (a) virtual education and (b) case-based consultation. The investigators hypothesize that PATH will improve organizational-level PRSS burnout, additional workforce outcomes, and HR service quality.

Conditions

  • Burnout
  • Compassion Satisfaction
  • Secondary Trauma

Interventions

BEHAVIORAL

PATH (Peer Advanced Training in Harm reduction)

PATH is an educational workforce intervention for improving peer recovery support specialists' (PRSS) harm reduction (HR) service delivery ability and quality and as a PRSS workforce and service system support. PATH will include 3 hours of eLearning modules and 8 weekly ECHO (Extension for Community Health Outcomes) meetings lasting 1.5 hours each, delivered over 2 months. Each ECHO session includes a 30-minute presentation followed by one hour of case-based discussion about a real client or problem. The entire PATH intervention will take 15 hours (3 hours of eLearning and 12 hours of ECHO participation) over 3 months. Participants are expected to complete all 15 hours, completing the 3 hours of eLearning before starting the 12 hours of ECHO activities.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • Chestnut Health Systems

    lead OTHER

Principal Investigators

  • Dennis P Watson, PhD · Chestnut Health Systems

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-12
Primary Completion
2026-04-30
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07218562 on ClinicalTrials.gov